Amaliris Guerra Expresses Respect for Hal Drakesmith’s Contributions to the Iron Field
Amaliris Guerra, Research Scientist at Children’s Hospital of Philadelphia, reposted from MRC Weatherall Institute of Molecular Medicine on LinkedIn:
”Iron is not just a micronutrient in the background. In inflammation, it becomes a control knob, shaping immune metabolism, signaling, and downstream outcomes.
I just read “Iron and the immune system” (Nature Reviews Immunology) by Frost and Drakesmith, and it is one of the most cohesive, mechanism-forward syntheses of why iron belongs at the center of immunology, not on the periphery.
Major respect to Hal Drakesmith for consistently pushing the field toward clarity that actually translates.
This review hit home because it aligns tightly with my work: how iron delivery and iron sensing reshape immune behavior during chronic inflammation, and how those same iron circuits compete with the demands of erythropoiesis.
My NIH-funded, awardee training supported research into the signaling biology of iron-bound monoferric transferrin forms and transferrin receptors (TFR1 and TFR2) under inflammatory conditions, with a particular focus on how transferrin form can influence the fate and function of the adaptive immune response.
I also helped design and characterize custom mouse models that perturb iron delivery and sensing to uncover actionable biology in anemia of inflammation and immune-driven disease.
Looking ahead, I am enthusiastic to work with academic or industry partners as an independent scientist and consultant.
I would especially love to build with teams tackling high-stakes experimental questions in immunology, inflammation, infection, and iron biology.
A few ways I can support:
• Experimental strategy and study design: refine the question, select the right model(s), define decisive endpoints, and build studies that cleanly test mechanism
• Data analysis and interpretation: translate complex results into a defensible mechanistic story and a clear next-step decision tree
• Manuscript development: structure, figure logic, narrative flow, and precise scientific writing (including reviewer-proofing)
I deliver rigorous, discreet scientific support with strict IP protection and confidentiality.
To schedule a free introductory consult, message me here or email [email protected].”
Quoting MRC Weatherall Institute of Molecular Medicine‘s post:
”WIMM Reads: Iron is essential for life but it is also a battleground between the immune system and pathogens.
In a new review published in Nature Reviews Immunology, Hal Drakesmith and Joe N Frost examine how immune cells acquire and use iron, which immune pathways are most affected, and how iron availability influences infection, inflammatory disease, and cancer immunity.
With iron imbalance common worldwide, this work highlights key unanswered questions and potential therapeutic opportunities to shape immune responses by controlling iron handling.”
Read the full article in Nature Reviews Immunology.
Article: Iron and the immune system
Authors: Joe N. Frost, Hal Drakesmith

Stay updated on all scientific advances with Hemostasis Today.
-
Jul 8, 2026, 14:17Maha Othman: Advancing Thrombosis and Hemostasis Research at ISTH 2026
-
Jul 8, 2026, 14:07Zain Khalpey: Atrial Fibrillation as the Hidden Driver of Preventable Ischemic Stroke
-
Jul 8, 2026, 11:33Ifeanyichukwu Ifechidere: Haemophilia A and B – From First Diagnosis to the Era of Gene Therapy
-
Jul 8, 2026, 10:29Bringing Hemophilia Care Closer to Communities in Togo – WFH
-
Jul 8, 2026, 10:12Natasha Jolakoski: Completing Advanced Training in Thrombosis and Hemostasis
-
Jul 8, 2026, 09:58Rola Ghasoub: Early Intracranial Hemorrhage Remains the Main Barrier to Cure in Acute Promyelocytic Leukemia
-
Jul 8, 2026, 05:53Excellent PhD Defense by Roberta Cirsmaru on Gene Therapy for Hemophilia A – CRH French Reference Center for Hemophilia Lyon
-
Jul 8, 2026, 05:48Riccardo Menandro: How Lipid Nanoparticles Are Shaping the Future of Rare Disease and Hemophilia Treatment
-
Jul 8, 2026, 05:39Daniel Victor Ortigoza: New Evidence from ATLANTIS-4D-CT on Apixaban and Subclinical Valve Thrombosis